About Nona Biosciences
Nona Biosciences is a company based in Cambridge (United States) founded in 2022 by Jingsong Wang. It operates as a B2B. Nona Biosciences offers products and services including Harbour Mice Platform, Beacon Single B Cell Screening, and HCAb Harbour Mice. Nona Biosciences operates in a competitive market with competitors including Benchsci, Antiverse, EPITOPIC, Deep Biologics and NatIgGs, among others.
- Headquarter Cambridge, United States
- Founders Jingsong Wang
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nona Biosciences
Nona Biosciences offers a comprehensive portfolio of products and services, including Harbour Mice Platform, Beacon Single B Cell Screening, and HCAb Harbour Mice.
Transgenic mice for producing fully human antibodies.
System for antibody discovery through single cell analysis.
Platform generating heavy chain only antibodies for therapies.
People of Nona Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Nona Biosciences
Detailed funding history for Nona Biosciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nona Biosciences
Investment portfolio details for Nona Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nona Biosciences
Detailed financials for Nona Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nona Biosciences Comparisons
Peer comparison for Nona Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nona Biosciences
Nona Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benchsci, Antiverse, EPITOPIC, Deep Biologics and NatIgGs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
|
| Locked | Locked | Locked |
An AI platform for antibody drug discovery is provided.
|
|
| Locked | Locked | Locked |
Provider of cell therapy and antibody services
|
|
| Locked | Locked | Locked |
Provider of an AI-based antibody mining and screening platform for R&D work
|
|
| Locked | Locked | Locked |
Biotech startup discovers and improves natural antibodies for brain disease treatments using AI.
|
Detailed competitors of Nona Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nona Biosciences
Complete news archive for Nona Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nona Biosciences
Nona Biosciences was founded in 2022.
Nona Biosciences is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Jingsong Wang is the current CEO of Nona Biosciences. They have also founded this company.
Nona Biosciences specializes in antibody discovery and development using proprietary platforms like Harbour Mice. They provide integrated services from antigen design to IND readiness, focusing on fully human antibodies for therapies. Based in the US, they collaborate with academic institutions, startups, and biopharmaceutical companies on over 250 projects with more than 100 partners, emphasizing innovative biotechnology solutions.
Nona Biosciences's top competitors include Antiverse, Benchsci and Deep Biologics.
Nona Biosciences offers Harbour Mice Platform, Beacon Single B Cell Screening, and HCAb Harbour Mice.